Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
DaCosta A et al. |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. |
2017 |
J. Cyst. Fibros. |
pmid:28495380
|
Sharifi R et al. |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
2017 |
Lipids |
pmid:28493185
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Aktas AH and Saridag AM |
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. |
2017 |
J Chromatogr Sci |
pmid:28449104
|
Koštrun S et al. |
Around the macrolide - Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. |
2017 |
Eur J Med Chem |
pmid:28410508
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Kuo YT et al. |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. |
2017 |
Lancet Gastroenterol Hepatol |
pmid:28781119
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Painsi C and Lange-Asschenfeldt B |
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection. |
2017 |
Br. J. Dermatol. |
pmid:28731256
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Jung YS et al. |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28497487
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Olesen JS et al. |
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. |
2017 |
BMJ Case Rep |
pmid:28137898
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|